Form D · Biotechnology
Bone Biologics Corp
Burlington, MA · CIK 0001419554
Offering snapshot reported Nov 29, 2023 · SEC filing
- Reported sold
- $729K Offering amount: $729K
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 16, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 29, 2023 | Initial | $729,000 | No comparison | 4 | SEC filing |
| Jul 23, 2018 | Initial | $5,869,979 | No comparison | 4 | SEC filing |
| Mar 30, 2018 | Amendment | $1,900,000 | $500,000vs Aug 30, 2017 | 2 | SEC filing |
| Aug 30, 2017 | Initial | $1,400,000 | No comparison | 2 | SEC filing |
| Mar 23, 2016 | Initial | $0 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $51K
- Finders' fees
- $0
- Form D file number
- 021-498325
Represents aggregate exercise proceeds that may be received upon exercise of warrants to purchase up to 1,139,063 shares at an exercise price of $0.64 per share.
Comprised of a total cash fee equal to 7.0% of the aggregate gross proceeds of the offering. The issuer also issued to placement agent or its designees warrants to purchase up to 68,344 shares at an exercise price of $0.80 under Section 4(a)(2).
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| H.C. Wainwright & Co., LLC | 375 |
Source: Form D, filed Nov 29, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Siddhesh Angle | Director |
| John Booth | Director |
| William Coffin | Director |
| Jimmy Delshad | Director |
| Jeffrey Frelick | Executive |
| Jeff Frelick | Executive |
| Don R. Hankey | Director |
| Bret Hankey | Director |
| Steve La Neve | Executive |
| Stephen R La Neve | Director, Executive |
| Erick Lucera | Director |
| Chia Soo | Director |
| Bruce Stroever | Director |
| Deina H. Walsh | Executive |
| Benjamin Wu | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2 Burlington Woods Drive Ste 100
Burlington, MA, 01803
Burlington, MA, 01803